NEW YORK, Sept. 27, 2017 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All Persons or Entities who purchased Landauer, Inc. (“Landauer” or the “Company”) (NYSE:LDR) stock prior to September 6, 2017.
You are hereby notified that a class action complaint has been filed in Delaware District Court challenging the fairness of the sale of Landauer to Fortive Corporation (NYSE:FTV) for $67.25 per share. The transaction has a total value of $770 million. To learn more about the action and your rights, go to:
http://www.zlkdocs.com/LDR-Info-Request-Form-ma-6076
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
Levi & Korsinsky is a national firm with offices in New York, Connecticut, California, and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com


TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
California DMV Proposes New Safety Rules for Autonomous Vehicles After Waymo Incidents
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Brazilian Oil Workers’ Strike Continues as Key Petrobras Union Rejects Proposal 



